Study for model of diabetic nephropathy and prevention of disease progress

糖尿病肾病模型及预防疾病进展的研究

基本信息

  • 批准号:
    06557064
  • 负责人:
  • 金额:
    $ 7.87万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1996
  • 项目状态:
    已结题

项目摘要

Diabetic nephropathy is one of the most important diseases for cause of endstage kidney disease. The pathogenesis and treatment of the disease are critical for medical and social problems. Diabetic complications are mediated by advanced glycation endproducts (AGE) which produced by long-term reaction between proteins and high glucose condition. This study was designed to establish the model of diabetic nephropathy and to study the mechanism and the prevention of disease progress. We analyzed knockout mice for apolipoprotein E that developed the progressive glomerulosclerosis in association with glomerular hypertrophy. Mesangial cells had a low affinity receptor for AGE (RAGE) and increased the synthesis of extracellular matrix including type IV collagen. This reaction was mediated by specific DNA binding protein for promoter of type IV collagen (Alp145), which had multifunctions including DNA replication factor C and DNA binding proteins for promoter of angiotensinogen. The expression … More of Alp145 was correlated with glomerular sclerosis and cell proliferation in vivo model. Furthermore, we applied the hammerhead ribozyme for targeting RAGE and established a stable cell line that produced RAGE-specific ribozyme. The induction of type IV mRNA by AGE on mesangial cell was inhibited by RAGE-specific ribozyme. Heat shock protein 47 (HSP47) is a collagen-specific chaperone that has a major role during the biosynthesis and secretion of procollagen molecules. The expression of HSP47 increased in parallel with the expression of collagens during the progression of glomerulosclerosis in renal ablation rats. The administration of antisense oligonucleotides against HSP47 at the induction of anti-thy-1 glomerulonephritis markedly suppressed the increased production of collagens and attenuated the histological manifestations of desease. This study provides to establish the model for typical glomerulosclerosis, to determine the mechanisms of disease progression, and to further develop new strategy for prevention of disease progression. Less
糖尿病肾病是终末期肾病的重要病因之一。该病的发病机制和治疗是医学和社会问题的关键。糖基化终末产物(AGE)是蛋白质与高糖长期反应产生的产物,是糖尿病并发症的重要介导因素。本研究旨在建立糖尿病肾病模型,探讨糖尿病肾病的发病机制及防治措施。我们分析了敲除载脂蛋白E的小鼠,这些小鼠发展为与肾小球肥大相关的进行性肾小球硬化。系膜细胞对AGE(AGE)有低亲和力受体,并增加细胞外基质(包括IV型胶原)的合成。该反应由IV型胶原启动子特异性DNA结合蛋白(Alp 145)介导,Alp 145具有DNA复制因子C和血管紧张素原启动子DNA结合蛋白等多功能。表达 ...更多信息 Alp 145的表达与肾小球硬化和细胞增殖相关。此外,我们将锤头状核酶应用于靶向RAGE,并建立了稳定的产生RAGE特异性核酶的细胞系。RAGE特异性核酶可抑制AGE对系膜细胞IV型mRNA的诱导。热休克蛋白47(HSP 47)是一种胶原特异性分子伴侣,在前胶原分子的生物合成和分泌过程中起重要作用。在肾切除大鼠肾小球硬化过程中,HSP 47的表达与胶原的表达呈平行增加。在诱导抗Thy-1肾小球肾炎时给予HSP 47的反义寡核苷酸可明显抑制胶原的产生,减轻疾病的组织学表现。本研究为建立典型肾小球硬化模型,探讨疾病进展机制,进一步开发预防疾病进展的新策略提供了实验依据。少

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yokode,M.Ueyama,K.Nagare,Y.Arai,H.Ueda,Y.and Kita,T.: "Modification of high-and low-density lipoproteins by cigarette smoke oxidants." Ann N.Y.Acad Sci.786. 245-251 (1996)
Yokode,M.Ueyama,K.Nagare,Y.Arai,H.Ueda,Y.和Kita,T.:“香烟烟雾氧化剂对高密度脂蛋白和低密度脂蛋白的修饰。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Bernier, S.H., Utani, A., Sugiyama, S. Doi, I., Polistina, C., Yamada, Y.: "cloning and Expression of Laminin d_2 chain(M" Matrix Biology. 14. 447-455 (1994)
Bernier, S.H.、Utani, A.、Sugiyama, S. Doi, I.、Polistina, C.、Yamada, Y.:“层粘连蛋白 d_2 链的克隆和表达(M”) Matrix Biology. 14. 447-455 (1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
辻 博子: "Ribozyme targetting of receptor for advanced glycation end products in mesangial cells" Biochemical and Biophysical Research Communications. 245. 583-588 (1998)
Hiroko Tsuji:“核酶靶向系膜细胞中高级糖基化终产物的受体”《生物化学和生物物理研究通讯》245. 583-588 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小松 武生: "Demorstration of DNA replication factor Cin human glomerular lesions" clinical nephrology. 49. 69-73 (1998)
Takefu Komatsu:“人肾小球病变中 DNA 复制因子 C 的演示”临床肾脏病学 49. 69-73 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sunamoto M,et.al.: "Expression of heat shock protein 47 is increased in remnant kidney and correlates with disease progression." International Journal of Experimental Pathology. (in press).
Sunamoto M 等人:“热休克蛋白 47 的表达在残肾中增加,并且与疾病进展相关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOI Toshio其他文献

DOI Toshio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOI Toshio', 18)}}的其他基金

Establishment of non-invasive diagnostic method for CKD by using urinary exosomes.
利用尿液外泌体建立慢性肾病无创诊断方法。
  • 批准号:
    23659445
  • 财政年份:
    2011
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of Specific Biomarker and Molecular Targeting Therapy for Diabetic Nephropathy by RAS-independent Pathway
通过RAS非依赖性途径开发糖尿病肾病特异性生物标志物和分子靶向治疗
  • 批准号:
    22390169
  • 财政年份:
    2010
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An International Collaborative Study to investigate Genetic Susceptibility for chronic Kidney Disease Which is Common in Asian
一项国际合作研究,调查亚洲常见慢性肾病的遗传易感性
  • 批准号:
    15406033
  • 财政年份:
    2003
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Study of Progressive Factors to Developing Glomerular Injury
肾小球损伤进展因素的研究
  • 批准号:
    12470210
  • 财政年份:
    2000
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation for progressive factors of glomerulosclerosis.
肾小球硬化进展因素的调查。
  • 批准号:
    10470216
  • 财政年份:
    1998
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Biological Study for the pathogenesis of glomerulosclerosis
肾小球硬化发病机制的分子生物学研究
  • 批准号:
    05454341
  • 财政年份:
    1993
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

白茅根抗肾小球肾炎物质基础及免疫机制研究
  • 批准号:
    30860363
  • 批准年份:
    2008
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
同种异体移植肾中复发性肾小球疾病的遗传学和免疫预测因子
  • 批准号:
    10637158
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes
丝氨酸蛋白酶 HTRA1 抗原:阐明膜性肾病发病机制和抗原表位靶向的途径
  • 批准号:
    10740614
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异N​​CF1.pR90H在促进肾脏损伤中的作用
  • 批准号:
    10740630
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
Glycan biomarker panels in liquid biopsies for predicting treatment response in lupus nephritis
液体活检中的聚糖生物标志物组用于预测狼疮性肾炎的治疗反应
  • 批准号:
    10601270
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
Rationally Designed, Target-specific Imaging Probes for Nephro-urology Diagnoses
用于肾泌尿科诊断的合理设计、针对特定目标的成像探头
  • 批准号:
    10659440
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
High-throughput identification and transcriptional analysis of autoreactive T cells in individuals with membranous nephropathy.
膜性肾病患者自身反应性 T 细胞的高通量鉴定和转录分析。
  • 批准号:
    10725558
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
Identifying autoimmune associated genes in patrolling monocytes that promote lupus nephritis
识别巡逻单核细胞中促进狼疮肾炎的自身免疫相关基因
  • 批准号:
    10726991
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
CureGN
治愈GN
  • 批准号:
    10877511
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
Preclinical and Clinical Models of Drug Induced Kidney Injury
药物性肾损伤的临床前和临床模型
  • 批准号:
    10745197
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus
脾脏调节 SHP-2 活性作为系统性红斑狼疮的治疗选择
  • 批准号:
    10668102
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了